Amicus Therapeutics Inc (FOLD)
9.80
-0.08
(-0.81%)
USD |
NASDAQ |
May 31, 16:00
9.82
+0.02
(+0.20%)
After-Hours: 20:00
Amicus Therapeutics Accounts Receivable (Quarterly): 76.43M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 76.43M |
December 31, 2023 | 87.63M |
September 30, 2023 | 73.33M |
June 30, 2023 | 63.72M |
March 31, 2023 | 68.18M |
December 31, 2022 | 66.20M |
September 30, 2022 | 52.30M |
June 30, 2022 | 52.56M |
March 31, 2022 | 52.42M |
December 31, 2021 | 52.67M |
September 30, 2021 | 51.43M |
June 30, 2021 | 49.17M |
March 31, 2021 | 44.93M |
December 31, 2020 | 46.92M |
September 30, 2020 | 44.83M |
June 30, 2020 | 43.04M |
March 31, 2020 | 40.56M |
December 31, 2019 | 33.28M |
September 30, 2019 | 33.73M |
June 30, 2019 | 28.71M |
March 31, 2019 | 22.96M |
December 31, 2018 | 21.96M |
September 30, 2018 | 14.19M |
June 30, 2018 | 15.08M |
March 31, 2018 | 10.84M |
Date | Value |
---|---|
December 31, 2017 | 9.464M |
September 30, 2017 | 5.974M |
June 30, 2017 | 3.786M |
March 31, 2017 | 1.875M |
December 31, 2016 | 1.304M |
September 30, 2016 | 0.864M |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 0.293M |
June 30, 2014 | 0.475M |
March 31, 2014 | 0.038M |
December 31, 2013 | 1.083M |
September 30, 2013 | 2.121M |
June 30, 2013 | 1.024M |
March 31, 2013 | 1.308M |
December 31, 2012 | 3.225M |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 5.043M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
28.71M
Minimum
Jun 2019
87.63M
Maximum
Dec 2023
53.10M
Average
51.86M
Median
Accounts Receivable (Quarterly) Benchmarks
Insmed Inc | 37.16M |
TG Therapeutics Inc | 64.98M |
Rhythm Pharmaceuticals Inc | 14.70M |
Alnylam Pharmaceuticals Inc | 321.38M |
InfuSystems Holdings Inc | 20.54M |